Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
25.1M
-
Shares change
-
-461K
-
Total reported value, excl. options
-
$374M
-
Value change
-
-$6.66M
-
Number of buys
-
32
-
Number of sells
-
-38
-
Price
-
$14.90
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2018
95 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q2 2018.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.1M shares
of 37.4M outstanding shares and own 66.98% of the company stock.
Largest 10 shareholders include NWQ Investment Management Company, LLC (3.46M shares), FRANKLIN RESOURCES INC (2.72M shares), WYNNEFIELD CAPITAL INC (2.68M shares), DIMENSIONAL FUND ADVISORS LP (2.31M shares), BlackRock Inc. (1.95M shares), VANGUARD GROUP INC (1.47M shares), ROYCE & ASSOCIATES LP (1.27M shares), HEARTLAND ADVISORS INC (816K shares), THOMSON HORSTMANN & BRYANT INC (675K shares), and ROYAL BANK OF CANADA (596K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.